Therapeutics: Integrin β1 (CD29)

Mouse studies suggest an agonist mAb targeting integrin β1 could help treat muscle injury in the elderly and in Duchenne muscular dystrophy (DMD). In a mouse model of muscle injury, the mAb increased ...